DE | Accessible presentation
Translations are powered by AI

These Munich startups are ripe for investment

Which startups have the best prospects of successfully completing a financing round soon? We take a look into the crystal ball and introduce you to five companies that are ripe for investment.

June 18, 2024 4 min reading time

IOmx
iOmx Therapeutics was founded in 2016 by two scientists who previously worked at the German Cancer Research Center (DKFZ) in Heidelberg. The startup specializes in Medicationsdesigned to prevent cancer from evading the body's immune system. iOmx Therapeutics began the ongoing Phase I clinical trial of its most promising compound in March 2023. The startup's research has been funded by Wellington Partners, Sofinnova Partners, M Ventures, and MIG Capital, among others. These and other investors have invested a total of €105 million in the startup to date. The most recent financing round—a €65 million Series B—was closed in October 2021. The dealroom signal is at 88 points. (Image: Markus Feuerer, Dieter Schröter / DKFZ)
read more ↓